CA2251702C - Biologically active composition - Google Patents

Biologically active composition Download PDF

Info

Publication number
CA2251702C
CA2251702C CA002251702A CA2251702A CA2251702C CA 2251702 C CA2251702 C CA 2251702C CA 002251702 A CA002251702 A CA 002251702A CA 2251702 A CA2251702 A CA 2251702A CA 2251702 C CA2251702 C CA 2251702C
Authority
CA
Canada
Prior art keywords
process according
weight
composition according
composition
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002251702A
Other languages
English (en)
French (fr)
Other versions
CA2251702A1 (en
Inventor
Ake Lindahl
Rickard Bryland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Publication of CA2251702A1 publication Critical patent/CA2251702A1/en
Application granted granted Critical
Publication of CA2251702C publication Critical patent/CA2251702C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002251702A 1996-04-30 1997-04-29 Biologically active composition Expired - Fee Related CA2251702C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9601665A SE9601665D0 (sv) 1996-04-30 1996-04-30 Biologically active composition
SE9601665-4 1996-04-30
PCT/SE1997/000721 WO1997040818A1 (en) 1996-04-30 1997-04-29 Biologically active composition

Publications (2)

Publication Number Publication Date
CA2251702A1 CA2251702A1 (en) 1997-11-06
CA2251702C true CA2251702C (en) 2007-01-09

Family

ID=20402417

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002251702A Expired - Fee Related CA2251702C (en) 1996-04-30 1997-04-29 Biologically active composition

Country Status (12)

Country Link
US (1) US6979454B1 (cg-RX-API-DMAC10.html)
EP (1) EP0952819B1 (cg-RX-API-DMAC10.html)
JP (1) JP4283892B2 (cg-RX-API-DMAC10.html)
AT (1) ATE345777T1 (cg-RX-API-DMAC10.html)
AU (1) AU701720B2 (cg-RX-API-DMAC10.html)
CA (1) CA2251702C (cg-RX-API-DMAC10.html)
DE (1) DE69736985T2 (cg-RX-API-DMAC10.html)
ES (1) ES2276425T3 (cg-RX-API-DMAC10.html)
NZ (1) NZ332497A (cg-RX-API-DMAC10.html)
SE (1) SE9601665D0 (cg-RX-API-DMAC10.html)
WO (1) WO1997040818A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA973705B (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
DK1871353T3 (da) * 2005-04-15 2011-04-04 Einstein Coll Med Vitamin k til forebyggelse eller behandling af hududslæt sekundært til anti-EGFR-terapi
US9428582B2 (en) * 2006-07-03 2016-08-30 Genmab A/S Method of treating rash in patients undergoing anti-EGFR therapy
ES2550481T3 (es) * 2007-08-16 2015-11-10 The University Of Chicago Resistencia a patógenos de plantas
US8815953B2 (en) * 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
CA2738970A1 (en) * 2008-10-31 2010-05-06 Moberg Derma Ab Topical composition comprising a combination of at least two penetration enhancing agents
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299828A (en) * 1979-05-31 1981-11-10 E. R. Squibb & Sons, Inc. Corticosteroid stick formulations
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
ATE107517T1 (de) * 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd Transdermales therapeutisches mittel.

Also Published As

Publication number Publication date
NZ332497A (en) 1999-05-28
SE9601665D0 (sv) 1996-04-30
ATE345777T1 (de) 2006-12-15
CA2251702A1 (en) 1997-11-06
AU701720B2 (en) 1999-02-04
AU2796997A (en) 1997-11-19
ES2276425T3 (es) 2007-06-16
JP2000509385A (ja) 2000-07-25
DE69736985T2 (de) 2007-09-20
ZA973705B (en) 1997-11-25
JP4283892B2 (ja) 2009-06-24
US6979454B1 (en) 2005-12-27
EP0952819B1 (en) 2006-11-22
WO1997040818A1 (en) 1997-11-06
EP0952819A1 (en) 1999-11-03
DE69736985D1 (de) 2007-01-04

Similar Documents

Publication Publication Date Title
US5061700A (en) Glyceryl acetate ointment vehicles
US5104656A (en) Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent
WO1993000106A1 (en) External preparation containing cyclosporin
JP4350269B2 (ja) 化粧料添加用組成物
AU9002601A (en) Novel topical oestroprogestational compositions with systemic effect
JPS62186936A (ja) ステリン乳化乃至可溶化組成物
WO2004041287A1 (en) Delivery composition and method
JP2022501314A (ja) 局所用組成物
AU701720B2 (en) Biologically active composition
PL202852B1 (pl) Kompozycja farmaceutyczna do stosowania miejscowego zawierająca nimesulid i sposób wytwarzania kompozycji
JP2015227354A (ja) モメタゾンとプロピレングリコールとの水中油型エマルジョン
WO1994026234A1 (en) Water-in-oil emulsion compositions
JPH0413624A (ja) ピロキシカム含有局所投与用医薬組成物
JP3803595B2 (ja) 尿素含有皮膚外用組成物
SK70497A3 (en) External antiinflammatory agent and method of producing it
DE3230602C2 (cg-RX-API-DMAC10.html)
JPS62215528A (ja) 経皮投与製剤
EP2429490B1 (en) Oil-in-water emulsion of mometasone
JPH06287137A (ja) スルホニウム化合物含有皮膚外用剤
CA2156396A1 (en) Stable dermatologic preparation containing mycophenolic acid
CZ282830B6 (cs) Léčivá mast bez dráždivého účinku na kůži a způsob její přípravy
JPS6287528A (ja) N−アルキルモルホリン含有外皮投与用組成物
JPH0782147A (ja) インドメタシンファルネシル含有外用剤
CZ18493A3 (cs) Topický přípravek obsahující cyklosporin

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20170501